Navigation Links
Former CEO and Chair of the Council of Experts at the USP, Roger L. Williams, MD, Joins NDA Partners as a Premier Expert Consultant
Date:5/28/2015

Rochelle, Virginia (PRWEB) May 28, 2015

Dr. Carl Peck, MD, Chairman of NDA Partners LLC announced today that Roger L. Williams, MD, has joined the firm as a Premier Expert consultant. NDA Partners Premier Experts are top tier consultants whose expertise and professional stature enable them to bring extraordinary value to the company’s clients. Premier Experts collaborate to design and implement critical solutions to help clients successfully develop their medical products, pursue optimal regulatory pathways, build companies that are attractive to professional investors, and initiate access to global markets.

Dr. Williams is an expert in clinical pharmacology and Board certified in clinical pharmacology and internal medicine. He was most recently Chief Executive Officer and Chair of the Council of Experts at the US Pharmacopeial Convention (USP). Prior to that he served in various positions at the FDA Center for Drug Evaluation and Research (CDER), including Director of the Office of Generic Drugs; Deputy Center Director, Office of Pharmaceutical Sciences; and Acting Director for New Drug Chemistry. He took on leadership roles nationally and internationally for FDA at the World Health Organization, the Pan American Health Organization, and, as FDA lead, the International Conference on Harmonization. In these capacities, Dr. Williams contributed to many important initiatives, including a WHO guidance, which supported interchangeable multisource medicines, and many guidances on the topics of safety, efficacy, quality, and regulatory communications at ICH.

“Dr. Williams’ expertise in pharmacology will be invaluable to our clients in every stage of drug development. He is also a proven leader, nationally and internationally, making him a welcome addition to the NDAP team.” said Dr. Peck

Dr. Williams is a fellow of the American Association of Pharmaceutical Scientists and a former expert member of the International Pharmacy Federation Board of Pharmaceutical Sciences. He has received a Doctor of Science degree, honoris causa, from Long Island University and has authored or co-authored more than 200 publications on topics related to applied regulatory and compendial science as well as national and international health.
.
About NDA Partners
NDA Partners is a strategy consulting firm specializing in expert product development and regulatory advice to the medical products industry and associated service industries such as law firms, investment funds and government research agencies. The highly experienced Principals and Premier Experts of NDA Partners include two former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; an international team of approximately 40 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and virtual product development teams.

Read the full story at http://www.prweb.com/releases/2015/05/prweb12746818.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related biology technology :

1. Jennifer C. Smith, DVM DACLAM, Formerly of Taconic Farms, Inc. Joins the Veterinary Bioscience Institute as the Vice President of Research and Development
2. Utah, There is No Better Place U.S. Chamber of Commerce Ranks Utah as the Top Performer in the Nation
3. SynCardia Total Artificial Heart Bridges Former Semi-Pro Arena Football Player to Heart Transplant
4. Microvi Biotechnologies Appoints Former COO of Zenon Environmental as Chairman of Board of Directors
5. MEI Pharma Adds Former YM BioSciences CEO Nick Glover To Board Of Directors
6. Former COO and CSO of IDEXX Laboratories, Inc. Joins Board of Directors for Vet-Stem, Inc.
7. Former Head of UK Medicines & Healthcare Products Regulatory Agency (MHRA) Sir Alasdair Breckenridge Joins NDA Partners
8. Former Life Technologies and BD Biosciences Executive John L. "Kip" Miller Joins Solulinks Board of Directors
9. McCord Research Hires Former University of Iowa Researcher
10. Regado Biosciences, Inc. Appoints World-Renowned Leader in Cardiovascular Research and Former Global Head of Cardiovascular Diseases for Merck & Co., to Board of Directors
11. Everest Group Recognizes TCS as a Global Leader and Star Performer in Life Sciences IT Outsourcing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2018)... ... August 16, 2018 , ... Ambry Genetics Corporation (“Ambry”), ... project were published today in JAMA Oncology, identifying new and confirming known hereditary ... , Every year hereditary breast cancer affects more than 20,000 women while hereditary ...
(Date:8/14/2018)... ... August 14, 2018 , ... The growing interest ... of the Chinese Association of Orthopaedic Surgeons (CAOS) held in partnership with the ... Development , Beijing, and Invibio Biomaterial Solutions partnered to demonstrate the ...
(Date:8/9/2018)... ... August 08, 2018 , ... InTouchMD , the leading provider of data ... be exhibiting at Biotech Week Boston , September 4th – 7th at Hynes ... platform, healthcare’s most powerful all in one marketing solution. Pulse is a multi-use ...
(Date:8/9/2018)... ... August 09, 2018 , ... Simpson ... construction (AEC) experts with building owners and managers for a full-day discussion on ... Construct symposium comes to Boston for the first time on Thursday, 13 September ...
Breaking Biology Technology:
(Date:8/9/2018)... ... August 08, 2018 , ... ... to invest in disruptive technology and healthcare companies, has invested in a sought-after ... stealth mode. , CRISPR Technology and Mammoth Biosciences , The biotech company ...
(Date:8/7/2018)... DIEGO (PRWEB) , ... August 07, 2018 , ... ... that accelerate pharmaceutical and biotherapeutics development, announces a new publication titled, “Synthetic ... Bioorganic & Medicinal Chemistry. The paper prominently features use of Agile R100, described ...
(Date:8/1/2018)... ... 2018 , ... Dr. Asher Kimchi, Founder and Chairman of the International ... Awards at the 23rd World Congress on Heart Disease held in Boston, MA, USA. ... the Distinguished Fellowship Awards. , Dr. Asher Kimchi, together with Chairman Dr. John A. ...
Breaking Biology News(10 mins):